Spatial Transcriptomics Market

Spatial Transcriptomics Market (Product Type: Consumables, Instruments, and Services; and Application: Clinical, and Drug and Biomarker Discovery and Development) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Spatial Transcriptomics Market Outlook 2034

  • The global industry was valued at US$ 358.9 Mn in 2023
  • It is projected to advance at a CAGR of 14.3% from 2024 to 2034 and reach more than US$ 1.6 Bn by the end of 2034

Analysts’ Viewpoint

Growth in demand for personalized medicine, surge in usage of spatial transcriptomics in drug discovery, rise in investments in R&D, and the advent of innovative spatial analysis instruments and software are bolstering spatial transcriptomics market development.

Spatial transcriptomics combine gene expression data of individual cells with mRNA transcript location information, in order to develop spatial maps of complex tissues and create better understanding of cell development pathways.

Besides structural understanding applications, spatial transcriptomics can also be employed for identification of drug targets, immune profiling, and to optimize computational biology.

Numerous players are offering innovative new-generation solutions in the spatial biology industry. Surge in collaborations and partnerships between healthcare entities and research institutions aimed at enhanced utilization of spatial transcriptomic technologies contribute significantly to market expansion.

Market Outlook

Spatial transcriptomics is a molecular profiling method that enables measurement of gene activity in a tissue sample and maps the location of its occurrence. The technology aids in identifying differentially expressed genes in predefined samples for designing profiles that can predict diagnosis or prognostic stages of molecular samples.

Spatial transcriptomics have emerged as distinct tools that systematically identify the three-dimensional location of RNA molecules across sub-cellular, cellular, as well as tissue levels.

Companies install their spatial instruments in research laboratories and academic institutes where scientists conduct their spatial research through collaborations with industry players to unveil biological discoveries. Once an instrument is installed, consumables are required on a repetitive basis for conducting analytical tests.

Several players engaged in this industry offer spatial transcriptomic services to consumers, for spatial profiling of given set of samples. This approach is often more economical than setting up spatial transcriptomics research laboratories.

Spatial transcriptomics are increasingly being used for drug discovery and biomarker identification. Spatial biology platforms can potentially accelerate translational drug discovery through detailed phenotypic immunoassays, characterization of tissue structures, investigation of tumor heterogeneity, and assessment of biomarker expression in disease-affected cellular / tissue regions.

Attribute Detail
Drivers
  • Surge in Utilization of Spatial Transcriptomics in Drug Discovery
  • Rise in Demand for Novel, Technologically Advanced Spatial Analysis Tools

Surge in Utilization of Spatial Transcriptomics in Drug Discovery Fueling Spatial Transcriptomics Market Size

The expeditious growth of precision medicine and targeted therapies have led to remarkable advancements in identification and validation of molecular biomarkers associated with disease pathology, prognosis, and treatment response.

Spatial transcriptomics technologies serve as effective tools for revealing spatial gene expression signatures in tissues that could be used to discover new biomarkers and drug targets in-situ.

The platforms are used to record the changes in gene expression in tissue samples from where spatial organization of cells within complex tissue microenvironments can be established.

This spatially resolved molecular data aids in understanding disease pathology, thereby enhancing probability of discovery of new therapeutic targets for a wide range of indications including oncological disorders, neurological disorders, as well as autoimmune disorders.

Rise in Demand for Novel, Technologically Advanced Spatial Analysis Tools

As spatial transcriptomics developers are constantly innovating to improve product capabilities, high-throughput analytical instruments are being introduced for better workflow efficiency.

The surge in demand for innovative and technologically advanced solutions for complex processes is offering lucrative spatial transcriptomics market opportunities.

As researchers strive for advanced methods to spatially regulate gene expression in tissues, there is a growing need for novel spatial transcription solutions that provide flexible workflows and user-friendly interfaces.

Enhanced performance of spatial transcription systems combined with sophisticated technologies such as automation, microfluidics, and high-throughput sequencing have enabled researchers to generate spatially resolved gene expression data with unprecedented speed, sensitivity, and accuracy.

Thus, the introduction of novel, spatial analysis tools is expected to boost the spatial transcriptomics industry growth.

High Demand for Consumables

The spatial transcriptomics market segmentation based on product type includes consumables, instruments, and services. Consumables are expected to dominate during the forecast period.

Spatial transcriptomics instruments are expensive. Consumables are repetitive units that are required for operating the instruments. Research organizations with installed spatial transcriptomics instruments frequently acquire consumables to conduct spatial analyses on the system, thus driving the growth of the segment.

Drug and Biomarker Discovery and Development Gaining Traction

According to the spatial transcriptomics market analysis, based on application, the drug and biomarker discovery and development segment is expected to dominate. The segment has become the main focus of spatial transcriptomics industry growth.

Transcriptomics technologies allow researchers to investigate the spatial distribution of gene expression inside tissues, providing crucial insights into disease causes, biomarker identification, and therapeutic response.

Furthermore, the growth in emphasis on precision medicine and tailored therapies have spurred the need for spatial transcriptomics technology in biomarker development.

Regional Outlook of Spatial Transcriptomics Industry

Attribute Detail
Leading Region North America

As per the latest spatial transcriptomics market forecast, North America held dominant share in 2023. Advancement of healthcare infrastructure, increase in awareness, and augmented healthcare finances are driving market dynamics in the region.

In the U.S., several companies are engaged in the development of innovative spatial transcriptomics solutions to augment their market position. For instance, in April 2024, Vizgen Inc. launched the MERSCOPE Ultra Platform and MERFISH 2.0 chemistry at the American Association of Cancer Research (AACR) 2024 Annual Meeting.

The MERSCOPE Ultra Platform is a high plex in- situ spatial multiomic analysis system. The platform features combined capabilities of imaging area and throughput in a spatial transcriptomics imaging system, enabling the processing of 3 sq. cm tissue on a single slide.

In Europe, several research institutes are conducting spatial biology research, driving the spatial transcriptomics market share in the region. For instance, Macrogen Europe offers spatial transcriptomics services, leveraging 10x Genomics’ Visium technology to enable the formation of precise mRNA expression maps of tissue slides.

The Asia Pacific market for spatial transcriptomics is anticipated to expand at the highest CAGR, ascribed to an increase in number of device approvals, rise in adoption of automated instruments for drug discovery, and entry of multinational firms within the marketplace.

Analysis of Key Players

The spatial transcriptomics market is fragmented with the presence of a number of players. Emerging players in the spatial transcriptomics industry include 10x Genomics, Inc., NanoString Technologies, Inc., Akoya Biosciences, Inc., Bruker Corporation, Standard BioTools Inc. (Fluidigm), Bio-Techne Corporation, and Vizgen Inc.

Key Developments

  • In May 2024, Akoya Biosciences signed an agreement with NeraCare to develop market opportunities for Akoya’s PhenoImager HT platform and NeraCare’s Immunoprint assay to improve patient stratification and treatment selection for patients suffering from early-stage melanoma.
  • In April 2024, NanoString Technologies announced that its substantial assets will be acquired by Bruker Corporation, a global analytical instrument company, for a sum of US$ 392.6 million. The acquisition of NanoString’s market-leading technology ensures continuity of the company’s business operations and product development initiatives for customers.
  • In February 2024, Vizgen entered into a partnership with Scale Biosciences to combine their single-cell and spatial technologies to improve data analysis. Under the terms of the agreement, leveraging their respective technologies, Vizgen and ScaleBio would generate high resolution data from serial mouse brain tissue samples for single cell RNA-sequencing, single cell DNA methylation, and targeted spatial gene expression.

Each of these players have been have been profiled in the spatial transcriptomics market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Spatial Transcriptomics Market Snapshot

Attribute Detail
Size in 2023 US$ 358.9 Mn
Forecast Value in 2034 More than US$ 1.6 Bn
CAGR 14.3%
Forecast Period 2024-2034
Historical Data Available for 2020-2023
Quantitative Units US$ Mn/Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation
  • Product Type
    • Consumables
    • Instruments
    • Services
  • Application
    • Clinical
    • Drug and Biomarker Discovery and Development
  • End-user
    • Academic Institutes
    • Clinical and Life Science Laboratories
    • Pharmaceutical and Biotechnology Companies
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • 10x Genomics, Inc.
  • NanoString Technologies, Inc.
  • Akoya Biosciences, Inc.
  • Bio-Techne Corporation
  • Bruker Corporation
  • Standard BioTools Inc. (Fluidigm)
  • Vizgen Inc.
Customization Scope Available upon Request
Pricing Available upon Request

Frequently Asked Questions

How big was the global spatial transcriptomics market in 2023?

It was valued at US$ 358.9 Mn in 2023

How big will the spatial transcriptomics business be in 2034?

It is projected to reach more than US$ 1.6 Bn by the end of 2034

What will be the CAGR of the spatial transcriptomics industry during the forecast period?

The CAGR is anticipated to be 14.3% from 2024 to 2034

Which region will account for major share of the spatial transcriptomics sector during the forecast period?

North America is expected to account for largest share from 2024 to 2034

Who are the prominent spatial transcriptomics providers?

10x Genomics, Inc., NanoString Technologies, Inc., Akoya Biosciences, Inc., Bruker Corporation, Standard BioTools Inc. (Fluidigm), Bio-Techne Corporation, and Vizgen Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Spatial Transcriptomics Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Spatial Transcriptomics Market Analysis and Forecasts, 2020-2034

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Key Industry Developments

        5.2. Pricing Trends

        5.3. Overview of SRT Technologies Based on Sequencing and Imaging Strategies

    6. Global Spatial Transcriptomics Market Analysis and Forecasts, By Product Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast By Product Type, 2020-2034

            6.3.1. Consumables

            6.3.2. Instruments

            6.3.3. Services

        6.4. Market Attractiveness By Product Type

    7. Global Spatial Transcriptomics Market Analysis and Forecasts, By Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast By Application, 2020-2034

            7.3.1. Clinical

            7.3.2. Drug and Biomarker Discovery and Development

        7.4. Market Attractiveness By Application

    8. Global Spatial Transcriptomics Market Analysis and Forecasts, By End-user

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast By End-user, 2020-2034

            8.3.1. Academic Institutes

            8.3.2. Clinical and Life Science Laboratories

            8.3.3. Pharmaceutical and Biotechnology Companies

            8.3.4. Others

        8.4. Market Attractiveness By End-user

    9. Global Spatial Transcriptomics Market Analysis and Forecasts, By Region

        9.1. Key Findings

        9.2. Market Value Forecast By Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness By Country/Region

    10. North America Spatial Transcriptomics Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast By Product Type, 2020-2034

            10.2.1. Consumables

            10.2.2. Instruments

            10.2.3. Services

        10.3. Market Value Forecast By Application, 2020-2034

            10.3.1. Clinical

            10.3.2. Drug and Biomarker Discovery and Development

        10.4. Market Value Forecast By End-user, 2020-2034

            10.4.1. Academic Institutes

            10.4.2. Clinical and Life Science Laboratories

            10.4.3. Pharmaceutical and Biotechnology Companies

            10.4.4. Others

        10.5. Market Value Forecast By Country, 2020-2034

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Product Type

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Spatial Transcriptomics Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast By Product Type, 2020-2034

            11.2.1. Consumables

            11.2.2. Instruments

            11.2.3. Services

        11.3. Market Value Forecast By Application, 2020-2034

            11.3.1. Clinical

            11.3.2. Drug and Biomarker Discovery and Development

        11.4. Market Value Forecast By End-user, 2020-2034

            11.4.1. Academic Institutes

            11.4.2. Clinical and Life Science Laboratories

            11.4.3. Pharmaceutical and Biotechnology Companies

            11.4.4. Others

        11.5. Market Value Forecast By Country/Sub-region, 2020-2034

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Product Type

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Spatial Transcriptomics Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast By Product Type, 2020-2034

            12.2.1. Consumables

            12.2.2. Instruments

            12.2.3. Services

        12.3. Market Value Forecast By Application, 2020-2034

            12.3.1. Clinical

            12.3.2. Drug and Biomarker Discovery and Development

        12.4. Market Value Forecast By End-user, 2020-2034

            12.4.1. Academic Institutes

            12.4.2. Clinical and Life Science Laboratories

            12.4.3. Pharmaceutical and Biotechnology Companies

            12.4.4. Others

        12.5. Market Value Forecast By Country/Sub-region, 2020-2034

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of APAC

        12.6. Market Attractiveness Analysis

            12.6.1. By Product Type

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Spatial Transcriptomics Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast By Product Type, 2020-2034

            13.2.1. Consumables

            13.2.2. Instruments

            13.2.3. Services

        13.3. Market Value Forecast By Application, 2020-2034

            13.3.1. Clinical

            13.3.2. Drug and Biomarker Discovery and development

        13.4. Market Value Forecast By End-user, 2020-2034

            13.4.1. Academic Institutes

            13.4.2. Clinical and Life Science Laboratories

            13.4.3. Pharmaceutical and Biotechnology Companies

            13.4.4. Others

        13.5. Market Value Forecast By Country/Sub-region, 2020-2034

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of LATAM

        13.6. Market Attractiveness Analysis

            13.6.1. By Product Type

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Spatial Transcriptomics Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast By Product Type, 2020-2034

            14.2.1. Consumables

            14.2.2. Instruments

            14.2.3. Services

        14.3. Market Value Forecast By Application, 2020-2034

            14.3.1. Clinical

            14.3.2. Drug and Biomarker Discovery and Development

        14.4. Market Value Forecast By End-user, 2020-2034

            14.4.1. Academic Institutes

            14.4.2. Clinical and Life Science Laboratories

            14.4.3. Pharmaceutical and Biotechnology Companies

            14.4.4. Others

        14.5. Market Value Forecast By Country/Sub-region, 2020-2034

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of MEA

        14.6. Market Attractiveness Analysis

            14.6.1. By Product Type

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Company Profiles

            15.1.1. Akoya Biosciences, Inc.

                15.1.1.1. Company Overview

                15.1.1.2. Financial Overview

                15.1.1.3. Product Portfolio

                15.1.1.4. Business Strategies

                15.1.1.5. Recent Developments

            15.1.2. Bruker Corporation

                15.1.2.1. Company Overview

                15.1.2.2. Financial Overview

                15.1.2.3. Product Portfolio

                15.1.2.4. Business Strategies

                15.1.2.5. Recent Developments

            15.1.3. Vizgen Inc.

                15.1.3.1. Company Overview

                15.1.3.2. Financial Overview

                15.1.3.3. Product Portfolio

                15.1.3.4. Business Strategies

                15.1.3.5. Recent Developments

            15.1.4. Bio-Techne Corporation

                15.1.4.1. Company Overview

                15.1.4.2. Financial Overview

                15.1.4.3. Product Portfolio

                15.1.4.4. Business Strategies

                15.1.4.5. Recent Developments

            15.1.5. 10x Genomics, Inc.

                15.1.5.1. Company Overview

                15.1.5.2. Financial Overview

                15.1.5.3. Product Portfolio

                15.1.5.4. Business Strategies

                15.1.5.5. Recent Developments

            15.1.6. Standard BioTools Inc. (Fluidigm)

                15.1.6.1. Company Overview

                15.1.6.2. Financial Overview

                15.1.6.3. Product Portfolio

                15.1.6.4. Business Strategies

                15.1.6.5. Recent Developments

            15.1.7. NanoString Technologies, Inc.

                15.1.7.1. Company Overview

                15.1.7.2. Financial Overview

                15.1.7.3. Product Portfolio

                15.1.7.4. Business Strategies

                15.1.7.5. Recent Developments

            15.1.8. Other Players

                15.1.8.1. Company Overview

                15.1.8.2. Financial Overview

                15.1.8.3. Product Portfolio

                15.1.8.4. Business Strategies

                15.1.8.5. Recent Developments

    List of Tables

    Table 01: Global Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Type, 2020-2034

    Table 02: Global Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Application, 2020-2034

    Table 03: Global Spatial Transcriptomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 04: Global Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Region, 2020-2034

    Table 05: North America Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Country, 2020-2034

    Table 06: North America Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034

    Table 07: North America Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Application, 2020-2034

    Table 08: North America Spatial Transcriptomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 09: Europe Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 10: Europe Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034

    Table 11: Europe Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Application, 2020-2034

    Table 12: Europe Spatial Transcriptomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 13: Asia Pacific Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 14: Asia Pacific Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034

    Table 15: Asia Pacific Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Application, 2020-2034

    Table 16: Asia Pacific Spatial Transcriptomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 17: Latin America Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 18: Latin America Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034

    Table 19: Latin America Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Application, 2020-2034

    Table 20: Latin America Spatial Transcriptomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 21: Middle East & Africa Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 22: Middle East & Africa Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034

    Table 23: Middle East & Africa Spatial Transcriptomics Market Value (US$ Mn) Forecast, by Application, 2020-2034

    Table 24: Middle East & Africa Spatial Transcriptomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    List of Figure

    Figure 01: Global Spatial Transcriptomics Market Value (US$ Mn) Forecast, 2020-2034

    Figure 02: Global Spatial Transcriptomics Market Value Share, by Product Type, 2023

    Figure 03: Global Spatial Transcriptomics Market Value Share, by Application, 2023

    Figure 04: Global Spatial Transcriptomics Market Value Share, by End-user, 2023

    Figure 05: Global Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034

    Figure 06: Global Spatial Transcriptomics Market Share Analysis, by Product Type, 2023

    Figure 07: Global Spatial Transcriptomics Market Share Analysis, by Product Type, 2034

    Figure 08: Global Spatial Transcriptomics Market Attractiveness Analysis, by Product Type, 2024–2034

    Figure 09: Global Spatial Transcriptomics Market Value (US$ Mn), by Consumables, 2020‒2034

    Figure 10: Global Spatial Transcriptomics Market Value Share Analysis, by Consumables, 2023 and 2034

    Figure 11: Global Spatial Transcriptomics Market Value (US$ Mn), by Kits and Instruments, 2020‒2034

    Figure 12: Global Spatial Transcriptomics Market Value Share Analysis, by Instruments, 2023 and 2034

    Figure 13: Global Spatial Transcriptomics Market Value (US$ Mn), by Services, 2020‒2034

    Figure 14: Global Spatial Transcriptomics Market Value Share Analysis, by Services, 2023 and 2034

    Figure 15: Global Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 16: Global Spatial Transcriptomics Market Share Analysis, by Application, 2023

    Figure 17: Global Spatial Transcriptomics Market Share Analysis, by Application, 2034

    Figure 18: Global Spatial Transcriptomics Market Attractiveness Analysis, by Application, 2024–2034

    Figure 19: Global Spatial Transcriptomics Market Value (US$ Mn), by Clinical, 2020‒2034

    Figure 20: Global Spatial Transcriptomics Market Value Share Analysis, by Clinical, 2023 and 2034

    Figure 21: Global Spatial Transcriptomics Market Value (US$ Mn), by Drug and Biomarker Discovery and development, 2020‒2034

    Figure 22: Global Spatial Transcriptomics Market Value Share Analysis, by Drug and Biomarker Discovery and development, 2023 and 2034

    Figure 23: Global Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 24: Global Spatial Transcriptomics Market Share Analysis, by End-user, 2023

    Figure 25: Global Spatial Transcriptomics Market Share Analysis, by End-user, 2034

    Figure 26: Global Spatial Transcriptomics Market Attractiveness Analysis, by End-user, 2024–2034

    Figure 27: Global Spatial Transcriptomics Market Value (US$ Mn), by Academic Institutes, 2020‒2034

    Figure 28: Global Spatial Transcriptomics Market Value Share Analysis, by Academic Institutes, 2023 and 2034

    Figure 29: Global Spatial Transcriptomics Market Value (US$ Mn), by Clinical and life science Laboratories, 2020‒2034

    Figure 30: Global Spatial Transcriptomics Market Value Share Analysis, by Clinical and life science Laboratories, 2023 and 2034

    Figure 31: Global Spatial Transcriptomics Market Value (US$ Mn), by Pharmaceutical and Biotechnology Companies, 2020‒2034

    Figure 32: Global Spatial Transcriptomics Market Value Share Analysis, by Pharmaceutical and Biotechnology Companies, 2023 and 2034

    Figure 33: Global Spatial Transcriptomics Market Value (US$ Mn), by Others, 2020‒2034

    Figure 34: Global Spatial Transcriptomics Market Value Share Analysis, by Others, 2023 and 2034

    Figure 35: Global Spatial Transcriptomics Market Value Share Analysis, by Region, 2023 and 2034

    Figure 36: Global Spatial Transcriptomics Market Share Analysis, by Region, 2023

    Figure 37: Global Spatial Transcriptomics Market Share Analysis, by Region, 2034

    Figure 38: Global Spatial Transcriptomics Market Attractiveness Analysis, by Region, 2023–2034

    Figure 39: North America Spatial Transcriptomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

    Figure 40: North America Spatial Transcriptomics Market Value Share Analysis, by Country, 2023 and 2034

    Figure 41: North America Spatial Transcriptomics Market Attractiveness Analysis, by Country, 2024–2034

    Figure 42: North America Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034

    Figure 43: North America Spatial Transcriptomics Market Attractiveness Analysis, by Product Type, 2024–2034

    Figure 44: North America Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 45: North America Spatial Transcriptomics Market Attractiveness Analysis, by Application, 2024–2034

    Figure 46: North America Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 47: North America Spatial Transcriptomics Market Attractiveness Analysis, by End-user, 2024–2034

    Figure 48: Europe Spatial Transcriptomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

    Figure 49: Europe Spatial Transcriptomics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

    Figure 50: Europe Spatial Transcriptomics Market Attractiveness Analysis, by Country/Sub-region, 2024–2034

    Figure 51: Europe Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034

    Figure 52: Europe Spatial Transcriptomics Market Attractiveness Analysis, by Product Type, 2024–2034

    Figure 53: Europe Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 54: Europe Spatial Transcriptomics Market Attractiveness Analysis, by Application, 2024–2034

    Figure 55: Europe Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 56: Europe Spatial Transcriptomics Market Attractiveness Analysis, by End-user, 2024–2034

    Figure 57: Asia Pacific Spatial Transcriptomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

    Figure 58: Asia Pacific Spatial Transcriptomics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

    Figure 59: Asia Pacific Spatial Transcriptomics Market Attractiveness Analysis, by Country/Sub-region, 2024–2034

    Figure 60: Asia Pacific Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034

    Figure 61: Asia Pacific Spatial Transcriptomics Market Attractiveness Analysis, by Product Type, 2024–2034

    Figure 62: Asia Pacific Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by Asia Pacific, 2023 and 2034

    Figure 63: Asia Pacific Spatial Transcriptomics Market Attractiveness Analysis, by Application, 2024–2034

    Figure 64: Asia Pacific Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 65: Asia Pacific Spatial Transcriptomics Market Attractiveness Analysis, by End-user, 2024–2034

    Figure 66: Latin America Spatial Transcriptomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

    Figure 67: Latin America Spatial Transcriptomics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

    Figure 68: Latin America Spatial Transcriptomics Market Attractiveness Analysis, by Country/Sub-region, 2024–2034

    Figure 69: Latin America Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034

    Figure 70: Latin America Spatial Transcriptomics Market Attractiveness Analysis, by Product Type, 2024–2034

    Figure 71: Latin America Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 72: Latin America Spatial Transcriptomics Market Attractiveness Analysis, by Application, 2024–2034

    Figure 73: Latin America Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 74: Latin America Spatial Transcriptomics Market Attractiveness Analysis, by End-user, 2024–2034

    Figure 75: Middle East & Africa Spatial Transcriptomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

    Figure 76: Middle East & Africa Spatial Transcriptomics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

    Figure 77: Middle East & Africa Spatial Transcriptomics Market Attractiveness Analysis, by Country/Sub-region, 2024–2034

    Figure 78: Middle East & Africa Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034

    Figure 79: Middle East & Africa Spatial Transcriptomics Market Attractiveness Analysis, by Product Type, 2024–2034

    Figure 80: Middle East & Africa Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 81: Middle East & Africa Spatial Transcriptomics Market Attractiveness Analysis, by Application, 2024–2034

    Figure 82: Middle East & Africa Spatial Transcriptomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 83: Middle East & Africa Spatial Transcriptomics Market Attractiveness Analysis, by End-user, 2024–2034

Copyright © Transparency Market Research, Inc. All Rights reserved